This is just one expert testimony in the Texas Senate hearings on vaccine mandates, May 16 2021. But it lines up with many other testimonies and reports and with the explosive situation revealed by VAERS and other official stats, so it’s hard to believe that only happens in Texas. And if it does, rest assured this is going to be the norm soon, whether officially reported or not. You don’t need medical knowledge anymore to tell that, we have enough data to be able to anticipate the trends using basic math now, as I’ve shown before and I’ve only been proven right since.

CLICK HERE TO WATCH ALMOST ONE HOUR OF DAMNING EXPERT TESTIMONIES FROM THE SAME HEARING!

Also see: HOW MANY THOUSANDS VAERS REPORTS IS CDC SITTING ON TO SELL MORE VACCINES?!

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

I have more memes confirmed than WHO has Covid cases

Pfizer sees Covid-19 as ‘durable’ revenue stream as profits rise

Pfizer CEO Albert Bourla at the Pfizer-BioNtech Covid-19 vaccine factory in Belgium, where capacity is ramping up

John BIERS, Tue, May 4, 2021, AFP via Yahoo News

Pfizer sharply increased its 2021 profit projections on Tuesday, citing much higher Covid-19 vaccine sales which are on track to provide a “durable” revenue stream in the wake of the pandemic.

The drugmaker reported a jump in first-quarter profits based on surging revenues, with nearly one-fourth of sales coming from Covid-19 vaccines.

With German partner BioNTech, the pharma giant is ramping up vaccine production and now estimates 2021 revenues of $26 billion from the vaccine, up from the $15 billion projected in February.

But the surging profits have drawn criticism as governments face pressure to step in to ensure vaccines are provided to underserved countries.

Pfizer, which says it is on the cusp of winning US approval for individuals 12 to 15 years old to receive its vaccine, is holding talks with “basically all governments of the world” about providing booster shots through 2024, Chief Executive Albert Bourla told analysts on a conference call Tuesday.

The company is studying the efficacy of giving the jabs six or more months after the second vaccine dose, and developing doses that could be stored at standard refrigerated temperature for up to 10 weeks.

Bourla expects “durable demand” for Covid-19 vaccines, similar to that of the flu vaccine.

“It is our hope that the Pfizer-BioNTech vaccine will continue to have a global impact by helping to get the devastating pandemic under control and helping economies around the world not only open, but stay open,” Bourla said in prepared remarks.

That would create “a scenario in which Pfizer can continue to be both a leader and a beneficiary,” he said.

Pfizer has won wide praise for its technological prowess in developing a game-changing vaccine in record time. However, critics called the profits troubling given the divide in vaccine availability between rich and poor countries.

World Health Organization chief Tedros Adhanom Ghebreyesus last month decried a “shocking imbalance in the global distribution of vaccines” and called for efforts to fortify the WHO’s Covax programs, which aims to ensure that poorer nations can access the shots.

India and South Africa are leading an effort in the World Trade Organization to waive intellectual property and patent rules, at least temporarily, which would open the door to broader production of vaccines at a time when the virus is causing mass misery in India and some other countries.

President Joe Biden said Tuesday he had not made a decision on whether to support a vaccine waiver, but that the United States was moving “as quickly as we can” to export doses.

Biden also said he was ready to “immediately” begin vaccinations for 12 to 15-year-olds as soon as Pfizer’s Covid shot is approved by regulators for the age group.

Pfizer reported net income of $4.9 billion, up 45 percent from the same period of the prior year.

Revenues also jumped 45 percent to $14.6 billion, including $3.5 billion in Covid-19 vaccine sales.

The results include the lift from Covid-19 vaccines, which generated profit margins of “high-20s,” implying around $900 million in profits in the most recent quarter.

As of May 3, Pfizer and BioNTech have shipped about 430 million doses of the vaccine to 91 countries around the world.

The company has reached an agreement to provide up to 40 million doses for Covax, a globally-pooled coronavirus vaccine procurement effort aimed at providing vaccines to low- and middle-income economies.

However, the company on Tuesday pointed to a series of deals to expand offerings in richer countries, including the United States, the European Union, Canada and Israel.

– Criticism of profits –

Pfizer has defended its approach to vaccine pricing, saying it has moderated pricing through a “pandemic phase” that could last into 2022 at levels “to encourage broad access.”

The company said it is charging $19.50 per vaccine dose in the United States, but has not disclosed its US profit margin.

Zain Rizvi, a law and policy researcher at progressive Public Citizen advocacy group, said Pfizer’s rising profits showed the need for governments to take action to save lives.

“Pfizer is cashing in on the crisis and hoarding technology, even as billions of people around the world go without a vaccine,” Rizvi said in an email to AFP.

“Pfizer’s profiteering shows the urgent need for governments to step-in. Governments should require Pfizer to share technology with manufacturers around the world to help ramp up global production.”

The company is building more capacity and expects to manufacture at least three billion doses in 2022, up from 2.5 billion now expected in 2021. In February, Pfizer said it expected to produce up to two billion doses in 2021.

Pfizer shares rose 0.3 percent to $39.95.

Pfizer sees robust COVID-19 vaccine demand for years, $26 bln in 2021 sales

REUTERS

Pfizer Inc (PFE.N) has just raised its forecast for 2021 COVID-19 vaccine sales by more than 70% to $26 billion and said demand from governments around the world fighting to halt the pandemic could contribute to its growth for years to come.

The company said it expects to file for full U.S. approval of the vaccine in May for people over the age of 16, as it is now only authorized for emergency use. It also expects to hear soon from U.S. regulators on expansion of the vaccine’s emergency use authorization (EUA) for children ages 12-15.

Revenue from the vaccine – developed with German partner BioNTech SE – is expected to account for more than one third of Pfizer’s sales this year.

The forecast is based on contracts to deliver 1.6 billion vaccine doses this year. The company expects to sign more deals for this year and is in supply talks with several countries for 2022 and beyond.

“Based on what we’ve seen, we believe that a durable demand for our COVID-19 vaccine – similar to that of the flu vaccines – is a likely outcome,” Chief Executive Albert Bourla said.

The two-shot vaccine was Pfizer’s top-selling product in the first quarter. Expenses and profit from the vaccine are split 50-50 between Pfizer and BioNTech.

Given persistent infections globally and ongoing discussions with governments, Mizuho analyst Vamil Divan said the 2021 forecast could increase further and spill over to future years.

Daily vaccination rates for adults in the United States are off more than 25% since hitting a peak in mid-April. Authorization in children would expand the vaccine-eligible population by millions of people.

Pfizer said it expects to have safety and efficacy data for children ages 2-to-11 in September, when it plans to ask for further expansion of the EUA for that age group.

The company has also filed new data with U.S. regulators that would allow the vaccine to be stored at standard refrigerator temperatures for up to four weeks, up from five days currently.

Pfizer logo seen outside their building in Manhattan, New York City, New York, U.S., March 2, 2021. REUTERS/Carlo Allegri/File Photo
Pfizer logo seen outside their building in Manhattan, New York City, New York, U.S., March 2, 2021. REUTERS/Carlo Allegri/File Photo

Pfizer and BioNTech aim to produce up to 2.5 billion COVID-19 vaccine doses this year, 900 million of which are not yet included in the New York-based drugmaker’s sales forecast.

If Pfizer sells that number of doses at similar prices, the vaccine’s sales in 2021 could be more than 50% above the projected $26 billion.

Moderna Inc (MRNA.O) has forecast $18.4 billion in 2021 sales of its similar COVID-19 vaccine.

Pfizer expects to profit from the vaccine, while some drugmakers including Johnson & Johnson (JNJ.N) have said their vaccine will be sold on a not-for-profit basis until the end of the pandemic.

Pfizer aims to manufacture at least 3 billion doses of the vaccine next year. It also expects to have safety and immunogenicity data from a third booster dose of the vaccine in July.

Pfizer and BioNTech have published data showing impressive durability for their vaccine at least six months after vaccination. Still, Bourla said he believes regular boosters will be needed to maintain high levels of immunity, and governments around the world have started signing deals for the shots.

The COVID-19 vaccine generated $3.5 billion in revenue in the first quarter, exceeding analysts’ estimates of $3.28 billion, according to Refinitiv data.

Total revenue for the quarter of $14.6 billion, topped analysts’ forecasts of $13.5 billion.

It plans to boost R&D spending to fuel drug discovery using the messenger RNA technology in the COVID-19 vaccine. The company is developing two flu vaccines that are expected to enter clinical trials in the third quarter.

Pfizer shares were down slightly in afternoon trading. – REUTERS

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

I have a feeling most of the World will be surprised to find out it was enrolled without informed consent in a vaccine trial

Australian Health Minister Greg Hunt has spilled the beans recently on live TV, for millions to hear, but when the mind is blind, you need to wait until the clip reaches some Romanian researcher stranded in Morocco, or something. Luckily the Internet can make this possible and here we are, maybe more people “click” now.

Normally, I avoid posting this type of sound-bites here without a consistent context, but I think this one deserves an exceptions because it speaks volumes in seconds and doesn’t really require much more context than I’ve already added.

Worth mentioning that, according to the ethical principles of clinical research, trial subjects for experimental medical treatments cannot be blood or organ donors.

BONUS, FOR AMUSEMENT

DEFINITELY NOT THAT LARGE, BY INDIAN SCALES.

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

You’ve likely heard of IG Farben, bud have you ever heard of American IG and the follow up story?

Imagine that the brutal experiments at Auschwitz were better concealed and the prisoners were drugged and brainwashed to believe that’s the best world out there for them. Then find out that the management has never stopped winning, expanding and perfecting their business model, up to today’s Great Reset.

good stuff that i had to leave out the video documentary:

Rockefellers brought the Nazi doctors and researchers to the US

SOURCE

ANSCO

Founded in Binghamton, New York, in 1901, Ansco was a manufacturer of photographic products and film. Ansco was originally founded through the merger of E. Anthony & Company and Scovill Manufacturing. In 1928, Ansco merged with Agfa to form Agfa-Ansco. The new corporation was a division of General Aniline and Film (GAF) Corporation, which was controlled by the German chemical cartel IG Farben. After Germany declared war on the United States in 1941, the United States Government seized the assets of GAF, including Agfa-Ansco. In 1943, the company removed “Agfa” from its name, once again becoming Ansco. The United States Justice Department oversaw Ansco’s operation until 1965, when government-held stock in GAF was sold to the public. In 1977, GAF eliminated its line of consumer photography products, including those manufactured by Ansco at the Binghamton facility. GAF also sold the Ansco trademark to Haking Enterprises. GAF continued to manufacture film at the Binghamton plant for industrial and medical use until 1981, when it sold the plant to Anitec Image Corporation. Over the next two decades, the former Ansco facility was sold several times, and in 2000, it was demolished.

Prior to the late 1970s, dozens of asbestos-containing materials were utilized in the construction and maintenance of buildings at Ansco’s Binghamton facility, including fireproof insulation, pipe covering and insulating cement. Inhaling dust from the application and removal of asbestos-containing materials placed workers at risk for developing an asbestos-related disease, such as mesothelioma or lung cancer.

Fireproof insulation was applied to structural steel during the construction of buildings at Ansco. Fireproofing materials were manufactured as a dry mixture of asbestos, linen and cement, packaged in fifty-pound paper bags. The dry mixture was mixed with water and sprayed onto the structural steel using a hose. Pouring, mixing and spraying fireproof insulation created clouds of asbestos-containing dust. After the fireproofing material was applied, it was typical for tradesmen, such as electricians or pipefitters, to scrape the fireproofing material from structural steel in order to install pipes and conduits. When the fireproof insulation was disturbed, asbestos fibers and dust became airborne.

Workers applied asbestos-containing pipe covering to pipes at the Binghamton Ansco facility. Pipe covering was applied to numerous piping systems in order to maintain stable internal temperatures and to protect pipes from damage. When pipe covering was applied, asbestos fibers were emitted. Insulating cement was also applied to pumps, valves and other equipment. It was manufactured as a powder and mixed with water to prepare it for application. Mixing insulating cement caused asbestos-containing dust to become airborne.

source:

What’s Bayer been up to lately?
We find out from their website:

The Bio Revolution is redefining innovation in the life sciences. How this might be a game changer.

The life sciences have made great advances in the past years. Biology, life sciences and the megatrend of digitization are growing closer together, enabling new inventions that impact our daily lives in a scope that we speak of a Bio Revolution. This revolution is reinforced by rapid increases in computing power and the emergence of new capabilities in AI, automation, and data analytics. These trends are further accelerating the pace of innovation and the potential for higher R&D productivity in the life sciences.

All this has led to new ways to understand and explore biology. The range of life forms on earth is incredibly complex and diverse. However, the methods to analyze them can be remarkably similar. Technologies and methods are transcending disciplinary boundaries even faster.

The implications across the life sciences can be enormous:

For human health, for example, a deeper understanding of the relationship between genetics and disease has led to the emergence of precision medicine, which can potentially be more effective than the one-size-fits-all therapies of the past. In the future, new technologies could help the healthcare industry not only treat, but cure or even prevent diseases. New gene and cell therapies, for example, aim to cure genetic diseases, potentially enabling sustainable organ replacement or reversing autoimmune diseases.

The Bio Revolution has the potential to help address some of the most critical global challenges, from climate change to pandemics, chronic diseases, and worldwide food security. Experts estimate that a significant portion of the economic impact of biological applications will be in health care, agriculture, and consumer products.3 Already today, the Bio Revolution with its convergence of science and technology has created an explosion of research projects in science and business. Each year, the amount of Intellectual Property related to the Bio Revolution is increasing.4 This can be seen, for example, by the number of patents in CrispR or plant biotech. In short: the revolution is gaining momentum and holds a great promise for health and food alike.

Total number of CRISPR patent applications worldwide per year from 1984 to 2018.

Quote symbolFueled by digitalization, growing connectivity, and falling costs, important advances in biotechnology are intertwined with more systemic shift in how bio-innovation is undertaken and who is involved. Microbiome technologies, advanced genomics, gene editing and synthetic biology are among key enabling technologies that have the potential to change the face of bio-innovation. This broader redefinition of bio-innovation creates new prospects to help address important nutrition, environmental and development needs.

World Economic Forum, Bio-Innovation Dialogue Initiative

.At the Forefront of the Bio Revolution

As a leading life science company, Bayer is aligned with the long-term market trends in health and nutrition and offers innovative and sustainable solutions to tackle some of the key challenges for humanity. Bayer brings to the table an extensive knowledge of human and plant science, supported by its expertise in regulatory processes and an impressive global footprint to ultimately bring innovations from labs to market. https://www.youtube-nocookie.com/embed/EYE1gya7XiM?autoplay=1&start=0&rel=0

The Bio Revolution marks the beginning of a new era: Innovations enabled by the convergence of biology and technology have the potential to significantly improve our lives, our nutrition, and our health.

Did you know that Bayer is at the forefront of the wave of innovation coming from the Bio Revolution?

The Bio Revolution is expected to transform healthcare and agriculture over the next decades – but the revolution is already happening now. With its newly established cell and gene therapy platform in Pharmaceuticals and innovative gene-editing tools such as CRISPR, Bayer operates at the core of the Bio Revolution and has tremendous opportunities to improve health and nutrition.

In Pharma, Bayer’s new Cell & Gene Therapy (CGT) platform steers our strategy in the area and orchestrates our activities along the value chain providing an innovation ecosystem for the companies – including BlueRock Therapeutics and Asklepios BioPharmaceutical (AskBio), which are fully owned by Bayer but operate autonomously. These therapies hold the potential to significantly impact patients’ lives by moving from treating symptoms to potentially curative approaches.

Bayer’s development portfolio of cell and gene therapies already comprises eight advanced assets in different stages of clinical development. These are applicable in multiple therapeutic areas with high unmet need, such as neurodegenerative, neuromuscular and cardiovascular indications, with programs in Pompe disease, Parkinson’s disease, hemophilia A, and congestive heart failure. With over 15 preclinical assets in the cell and gene therapy field, the pipeline is expected to grow steadily year by year.

Yet Bayer is not only using biotechnology to advance health – the promise for agriculture is just as inspiring. In the Crop Science Division, for example, tools like CRISPR can make changes to plant DNA with more precision than ever before and make plants more weather- or disease-resistant, enabling farmers to grow more or better-quality products under changing conditions.

Advancing genetic solutions for a sustainable future (1)PreviousNext

Did you know that Leaps by Bayer invests into potentially disruptive technologies to tackle some of the largest, unsolved challenges in the life sciences?

With Leaps by Bayer – our impact investment approach utilizing venture capital – we are constantly scanning for additional potential breakthroughs that hold promise to either cure or treat people from diseases or help feed a growing population with less impact on the environment.

$1 Billion

Since 2015, Leaps by Bayer has invested over $1 billion in ventures that tackle fundamental breakthroughs and shift core paradigms in our industries.

Leaps by Bayer has an investment focus on potentially disruptive solutions in the fields of healthcare and agriculture. The Leaps investment approach is remarkable: It aims to invest into or build up new innovative companies. Bayer supports those companies by enabling the exchange of proprietary assets, which can include sharing own patents or providing access to the Bayer network’s technical capabilities and 150 years of expertise. The companies remain autonomous with respect to decision making, while Leaps facilitates and supports them in a so-called active incubation process. Experienced team members actively engage in the young companies’ development by providing resources and helping them to steer the initial strategic direction. Today, the investment portfolio includes more than 35 companies advancing potential breakthrough technologies.

Quote symbolLeaps is our way of thinking big.

Werner Baumann, CEO of Bayer AG

Many Leaps ventures have made significant progress towards unlocking the potential of new technology platforms with a promising and transformative potential. BlueRock Therapeutics, for example, started as a Leaps investment and is now an integral part of Bayer’s CGT platform and just received clearance to proceed with a phase I trial in Parkinson’s disease.

Other companies, like the biopharmaceutical player Triumvira, are specialized on next generation immuno-oncology treatments. Triumvira focuses on novel T-cell therapies that aim to be safer and more efficacious than current cell therapy cancer treatments. Treating, curing and preventing cancer is one of the focus areas of Leaps by Bayer, since this group of diseases still represents one of today’s biggest health challenges with limited curative or preventative therapies available.

Quote symbolWe face a huge disease burden, and the way we produce food isn’t sustainable for the planet. I believe the Bio Revolution can help us overcome these issues.

Jürgen Eckhardt, Head of Leaps by Bayer

Leaps is also investing in the development of sustainable biotechnological solutions in the field of agriculture. One of the ventures in this field is Joyn Bio, a company that aims to significantly reduce the environmental impact of synthetic nitrogen fertilizers through a technology that fixes nitrogen into the soil. Nitrogen is one of the most important nutrients essential for every plant to grow, however, its use and production as a fertilizer is estimated to contribute 3-5% to all global greenhouse gas emissions. Joyn Bio is working on an engineered microbe that enables cereal crops like corn, wheat, and rice to convert nitrogen from the air into a form they can use to grow. This technology may have the potential to help farmers use nitrogen in new ways, and as a result, reduce agriculture’s environmental footprint.

Leaps portfolio

The Leaps by Bayer investment portfolio includes more than 35 companies.

At least that’s what Bayer says. All I know is that they’re still running the show.

Ex-Standard Oil

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

We gave up on our profit shares from masks, if you want to help us, please use the donation button!
We think frequent use, even short term use can be bad for you, but if you have no way around them, at least send a message of consciousness.
Get it here!

If you enabled this Covidiocracy in any way, I’m sorry for you! Even if you have a long life ahead of you, you’ll never experience peace of soul and happiness again.
And in no way you’re welcome to rule over or dictate to any living soul.

BONUS:

DOWNLOAD PDF

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER

WTH ever happened to “verify from three independent sources”?

These guys:

… just said this:

SHORT ATTENTION SPAN VERSION
FULL VERSION

Amazing list of investors, btw!

UPDATE #4: JUNE 4, 2021

BREAKING! 2ND BATCH OF FAUCI E-MAILS

UPDATE #1 : WE’VE JUST BEEN CONFIRMED BY THE UNFORTUNATE AMATEUR PROPAGANDISTS DISGUISED AS FRANCE PRESSE FACT-CHECKERS

SOURCE

ALL THEY HAVE IS A “POST IT” FROM CHINA!

Ah, and a “Nature publication”, I loled. o_O
What kind of people use “there is no question” as scientific argument/evidence? Pseudo-scientists, snake-oil salesmen and con artists of all kinds.

The sub-zeroes from the CBS-affiliate WUSA9 try to lend a helping hand to their owners, but they double down for us:

They link, as evidence, to this NIH page which ONLY MENTIONS GENBANK, which is the same fridge on which China stuck that “post it” note.
THAT IS ALL THEY HAVE.

WTH ever happened to “verify from three independent sources”?
It used to be Rule #0 in journalism, back when I studied it in college.

UPDATE2:
I discovered this when the video was already up…

Source

“Most of our readers are interested in consumer DNA testing for genealogy and ancestry research. Illumina played a massive role in making these services affordable. All the big DNA testing companies use Illumina’s chip technology.
But some companies are even more closely intertwined with Illumina. I mention briefly in an article on who owns 23andMe that the chip company was an investor in the 2015 funding found of its customer.”

https://www.dataminingdna.com/

“If you’ve ever used 23andMeAncestry.com, or any other genetics-testing service, chances are that your genes were sequenced on machines made by the $25 billion biotech behemoth. Now the undisputed leader in the emerging field of DNA sequencing in the U.S., Illumina has outstripped its rivals by selling its sequencing hardware to medical researchers around the world.”

https://www.fastcompany.com/

As we’ve shown in previous reports, 23andMe is owned by Richard Branson and a former wife and current partner of Google’s founder Sergey Brin. She also happens to be the sister of YouTube CEO.

“23andMe is owned by a sizeable number of large investors spearheaded by Anne Wojcicki and Richard Branson. The list of investors with recent ownership stakes in the company includes Altimeter Capital, Fidelity, Casdin Capital, and Foresite Capital.
Since the company was founded in 2006, it has been involved in multiple funding rounds. There were at least 60 investors in 2020 before the merger, including GlaxoSmithKline and Sequoia Capital. Early investors include Alphabet (Google’s parent company) and WuXi Healthcare Ventures (a Chinese company).
When 23andMe merged with Richard Branson’s acquisition company, the existing stakeholders retained ownership of 81% of the merged company.”

dataminingdna.com

According to Wikipedia:

“In 2005, co-founder and former Chief Scientific Officer Anthony Czarnik sued Illumina; see Czarnik v. Illumina Inc.

In 2010, Cornell University and Life Technologies filed a lawsuit against Illumina, alleging that its microarray products infringed on eight patents held by the university and exclusively licensed to the start-up. The case was settled in April 2017 without any finding of fault. In September 2017 both parties asked to have the settlement reviewed, with Cornell accusing both Illumina and Life Technologies of misrepresentation and fraud.[44]

In February 2020, Illumina filed a patent infringement suit against BGI relating to its “CoolMPS” sequencing products.[48] In return BGI has filed patent infringement lawsuits for violation of federal antitrust and California unfair competition laws, claiming use of “fraudulent behavior” to obtain or enforce sequencing patents that it has asserted against BGI, preventing the firm from entering the US market.[49]

“BGI” as in…

BILL GATES’ & BIG TECH’S CHINESE DARLINGS: WORLD’S TOP DNA HARVESTERS, CLONERS, UIGHUR PERSECUTERS (BIOHACKING P.4)

Ah, also…

source

UPDATE 3:

Sharryl Atkinson investigates the source of the virus, finds out no one in US got samples in their lab, moves on trying to find the source of a virus that no one can provide samples / isolation / purification.

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

If this scamdemic was possible, then our dream is possible too

Later edits:
HAPPY TO REPORT THIS IS SPREADING AND THE POLITBURO IS ALREADY IN DAMAGE CONTROL MODE

SOURCE

The Okanagan Valley in British Columbia, Canada is typically best known for its wineries, fruit orchards, and beautiful Okanagan Lake. But this week it’s making headlines based on a misguided misinterpretation of how the Covid-19 vaccines work. Steve Miller, owner of Sun City Silver and Gold Exchange, in the Okanagan city of Kelowna, spoke to Global News earlier this week: “We would rather not be exposed to people who have been vaccinated and who could shed the virus…Shedding is real, it’s a problem now and it is going to be a bigger problem as more and more people line up for these experimental vaccines.” There is also a sign banning mask-wearing inside the store. According to the city’s risk manager, the store is operating without a business license, and is promoting orders against those stated by local and regional public health officials.

Where does this notion of viral shedding after vaccination stem from, and is there any validity to this? As detailed in Victoria Forster’s recent Forbes piece, not only can’t you contract Covid-19 infection from the Covid-19 vaccine, you also cannot spread or shed virus from receiving the vaccine. This goes for any of the currently available Covid-19 vaccines, including those made by Pfizer-BioNTech, Moderna, Johnson & Johnson, and AstraZeneca.

Historically, and in some instances currently, some vaccines were made with either a reduced amount of live virus, such as smallpox, chickenpox, or measles, mumps rubella (MMR) or a small amount of inactivated/killed virus, such as hepatitis A, flu, or polio. Other vaccines, such as hepatitis B, human papillomavirus (HPV), and shingles (herpes zoster) use a tiny piece of a protein or sugar fragment from the pathogen. Still others are what’s know as toxoids, and are much shorter acting, as they provide only a miniscule amount of a toxin from the germ. Toxoid vaccines include diphtheria and tetanus, which last only five to ten years and require regular booster shots.

Both mRNA vaccines (Pfizer-BioNTech and Moderna) as well as both adenovirus-vector DNA vaccines (Johnson & Johnson and AstraZeneca) provide protection by enabling the recipient’s cells to produce the now infamous spike protein of SARS-CoV-2, or Covid-19. None of these vaccines enable the recipient to internally manufacture a virus. None of them. As Dr. Forster explained, “It’s like four tires on the starting grid of a racetrack, you know that they are car parts, but there’s no way someone can drive them around without the rest of it.” Spike proteins alone do not make a virus. The virus is comprised of RNA at its core, nucleoproteins, and the critical viral envelope, which protects it when it’s floating around looking for a host cell to grab onto with those spikes. Picture the image below with just the red spikes. They would fall to the bottom, as if a toddler smashed a well-constructed Lego set after you’ve already thrown out the instruction book, and managed to throw out a random number of critical pieces.

ATTENTION: PAY ATTENTION TO THE TRICK THEY’RE PLAYING ON SHORT-ATTENTION-SPANNED SUCKERS:
They debunk the viral shedding, NOT the spike protein shedding or other genetically modified compounds!
All fact-checkers I’ve read, about seven of them, play the same trick.
They’re pulling coins from covidiot ears.

Here’s A DOCTOR not accepting vaxxed patients!

 Miami school said that it wouldn’t allow vaccinated teachers in its classrooms, its founder cited “vaccine shedding” as her main concern.

At least one private school to place restrictions on teachers who are vaccinated before the end of the school year, as The New York Times reported, and even to threaten teachers who receive the vaccine over the summer:

“Even among our own population, we have at least three women with menstrual cycles impacted after having spent time with a vaccinated person,”
In the letter, Ms. Centner gave employees three options:

  • Inform the school if they had already been vaccinated, so they could be kept physically distanced from students;
  • Let the school know if they get the vaccine before the end of the school year, “as we cannot allow recently vaccinated people to be near our students until more information is known”;
  • Wait until the school year is over to get vaccinated.

Teachers who get the vaccine over the summer will not be allowed to return, the letter said, until clinical trials on the vaccine are completed, and then only “if a position is still available at that time” — effectively making teachers’ employment contingent on avoiding the vaccine.

Here’s one of those utter retards who can’t (or don’t want to) get we’re talking spike protein shedding, not viral shedding:


More citizens and doctors discussing the covid bioweapon effects on UNVAXXED PEOPLE

I am actually an early supporter of vaxxtards who insist on marking themselves with bracelets and other forms of yellow stars, makes them much easier to avoid, which is all I wish from the new emerging world!
If you volunteer for Auschwitz ad yellow stars, maybe that’s your vocation and you shouldn’t be stopped.
We also shouldn’t crowd your space with people like myself, who hate it to be around.

Also read: RUBICON CROSSED: COVIDIOTS PEED SO MUCH IN THE GENE POOL IT’S IRREVERSIBLY UNFREQUENTABLE

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

We gave up on our profit shares from masks, if you want to help us, please use the donation button!
We think frequent use, even short term use can be bad for you, but if you have no way around them, at least send a message of consciousness.
Get it here!

I survived many tough times focusing on the humor in them. And I find this highly amusing. But even more disturbing, when I look around and I see most people don’t flinch hearing such a claim.

Source

As for insurances and vaccines, the topic of that Forbes article… oh boy, oh boy… Check this out! And then THIS!

Follow up:

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

History​ lessons we haven’t learned. After the Renaissance, most human abominations had been backed by fabricated “science​ consensus”, it became a good sales pitch in some cases. The idea that the health of the public is more important than the health of the individual is older, and it’s the perfect excuse for eugenics; it has been revitalized and modernized by Nazis, and the Fourth Industrial Revolution aka The Fourth Reich is normalizing it now​. Pharmafia​ and its lemmings are deeply involved in the Nazi experiments (Bayer/Monsanto/BASF especially).
No abuse could’ve happened without the participation of those who took on themselves to protect us from suffering. Today, the people who “care” have aligned behind our planetary kidnappers, and the people who science for health have since normalized cancer in kids. It’s a never-ending self-feeding pandemic​ of moral failure and low intellectual effort

“Cizik School of Nursing has created a REMI Platinum Award-winning documentary film that tells the grim cautionary tale of nurses who participated in the Holocaust and abandoned their professional ethics during the Nazi era. The 56-minute film, Caring Corrupted: the Killing Nurses of the Third Reich, casts a harsh light on nurses who used their professional skills to murder the handicapped, mentally ill and infirm at the behest of the Third Reich and directly participated in genocide.” – Cizik School of Nursing

The Cizik School of Nursing at Health University of Texas is ranked in the Top 12 Percent of graduate nursing programs nationwide, according to the latest survey results by U.S. News and World Report. Nurse Anesthesia master’s/doctorate program (at No.8) still is ranked by U.S. News in the Top 10 in the U.S. Since 1972, Cizik School of Nursing has granted more than 12,022 nursing degrees to its graduates. For more information, go to: https://nursing.uth.edu/

DOWNLOAD PDF

UPDATE;

AMAZING INTERVIEW WITH HOLOCAUST SURVIVOR AND HUMAN RIGHTS CHAMPION VERA SHARAV CONFIRMS EVERYTHING WE’VE SHOWN AND MORE

Stand for Health Freedom recently had the honor of sitting down with Holocaust survivor Vera Sharav and capturing her personal story on film. It’s a story that every individual needs to hear.

Ms. Sharav is the founder and president of the Alliance for Human Research Protection, a nonprofit public watchdog organization dedicated to upholding informed consent in medicine. A renowned champion of human rights and expert in biomedical research ethics, Ms. Sharav offers rare and valuable insights into the public health arena and state of emergency affecting each and every one of our lives. She also shines a light on the corruption plaguing our national vaccine program —  and the decades-long targeting of Blacks, Hispanics and other minorities for unethical medical experiments.

You can learn more about Ms. Sharav and her pioneering work to protect children and human research subjects at ahrp.org.

Epilogue:

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

We gave up on our profit shares from masks, if you want to help us, please use the donation button!
We think frequent use, even short term use can be bad for you, but if you have no way around them, at least send a message of consciousness.
Get it here!